Cargando…
Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
BACKGROUND/AIMS: To identify predictive markers for the outcomes of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration (nAMD). METHODS: AURA was a retrospective, observational, multicentre study that monitored the 2-year outcomes following intravitreal r...
Autores principales: | Holz, Frank G, Tadayoni, Ramin, Beatty, Stephen, Berger, Alan, Cereda, Matteo Giuseppe, Hykin, Philip, Staurenghi, Giovanni, Wittrup-Jensen, Kim, Altemark, Andreas, Nilsson, Jonas, Kim, Kun, Sivaprasad, Sobha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256408/ https://www.ncbi.nlm.nih.gov/pubmed/27030279 http://dx.doi.org/10.1136/bjophthalmol-2015-308166 |
Ejemplares similares
-
Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
por: Holz, F G, et al.
Publicado: (2016) -
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
por: Holz, Frank G, et al.
Publicado: (2015) -
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008) -
Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
por: Gohil, Rishma, et al.
Publicado: (2015) -
A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
por: Hykin, Philip, et al.
Publicado: (2016)